PETS Petmed Express (PETS) Insider Trading, Ownership & Congress Trades
Wholesale & Retail · Retail-drug stores and proprietary stores · CIK 0001040130
SEC filings
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
19
13F, latest reported quarter
What the filings say about PETS
Insiders, 180 days
+$43.8K net bought
1 buyer
Petmed Express insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, PETMED EXPRESS INC insiders bought a net $43.8K of stock across 37 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Insider
Filed
Shares
Value
Since filing
Context
- 6 earlier Form 4 trades (code P or S) here by this insider (6 buys), the last on Jun 3, 2025.
- -17.2% median (-16.9% mean) 90-day return after 6 previous buys.
- The trade is 1.0% of the 2,600,000 shares held after it.
- No other insider bought within 30 days.
- 19 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider MATZ ZYMAN STEPHANNIE bought about $43.8K of PETS on Jun 8, 2026; 19 funds added in the latest 13F quarter.Context
- 6 earlier Form 4 trades (code P or S) here by this insider (6 buys), the last on Aug 1, 2025.
- -23.3% median (-22.7% mean) 90-day return after 6 previous buys.
- The trade is 3.9% of the 2,579,696 shares held after it.
- 1 other insider bought within 30 days.
- 19 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Silvercape Investments Ltd bought about $320.2K of PETS on Aug 13, 2025; 1 other insider bought within 30 days and 19 funds added in the latest 13F quarter.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 buys), the last on Jul 18, 2025.
- -23.3% median (-22.8% mean) 90-day return after 5 previous buys.
- The trade is 4.8% of the 2,478,696 shares held after it.
- 1 other insider bought within 30 days.
- 19 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Silvercape Investments Ltd bought about $379.4K of PETS on Aug 1, 2025; 1 other insider bought within 30 days and 19 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 buys), the last on Jan 27, 2025.
- -27.1% median (-27.1% mean) 90-day return after 4 previous buys.
- The trade is 1.0% of the 2,575,000 shares held after it.
- 1 other insider bought within 30 days.
- 19 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider TACHE GALANTE MOISES bought about $87.5K of PETS on Jul 21, 2025; 1 other insider bought within 30 days and 19 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 buys), the last on Jul 17, 2025.
- -23.7% median (-22.6% mean) 90-day return after 4 previous buys.
- The trade is 0.7% of the 2,360,496 shares held after it.
- 1 other insider bought within 30 days.
- 19 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Silvercape Investments Ltd bought about $56.7K of PETS on Jul 18, 2025; 1 other insider bought within 30 days and 19 funds added in the latest 13F quarter.37 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net +$43.8K over 180 days
+$43.8K of it by a 10%+ holder
more than 74% of Wholesale & Retail
Congress
no House purchase disclosed in the last 12 months
Funds
19 funds bought in last quarter
below 76% of Wholesale & Retail
Revenue
-21.1% year over year
below 88% of Wholesale & Retail
Margin
-32.0% net margin
below 86% of Wholesale & Retail
Buybacks
no share repurchases reported
Short interest
5.2% of the float short (float per yahoo 2026-10-26) · 4.2 days to cover · settled 2026-09-30
more than 53% of Wholesale & Retail
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch PETS
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-57.9%12M
Insider buy13D/G stake
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns PETS: institutional holders (13F)
13F holdings, latest reported quarter
1,131,230 sh
$2.2M
827,397 sh
$1.6M
568,255 sh
$1.1M
212,170 sh
$407.4K
204,075 sh
$391.9K
Congress trades in PETS
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
13D: intends to influence · 13G: passive
Diveroli Investment Group LLC
Activist 13D · 2026-02-11
1.83%
Kingbird Ventures LLC
Activist 13D · 2026-02-11
1.83%
PETS planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
PETS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Pinnacle Value Fund
$597.9K position · as of 2026-06-30
1.5%
Federated Hermes MDT Small Cap Value Fund f/k/a Federated Hermes Clover Small Value Fund
$224.3K position · as of 2026-06-30
0.1%
Federated Hermes MDT Small Cap Core ETF
$164.6K position · as of 2026-05-31
0.1%
Gabelli Global Mini Mites Fund
$7.7K position · as of 2026-06-30
0.0%
Ultra-Small Company Market Fund
$19.2K position · as of 2026-06-30
0.0%
EA Bridgeway Omni Small-Cap Value ETF
$158.1K position · as of 2026-06-30
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Hulett
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$534.0K
-$70.2K
$635.3K
-80%
n/a
2022
$534.1K
-$7.5M
$616.2K
-35%
+293%
2020
$2.2M
$2.4M
$784.7K
+26%
+398%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders are net buyers of their own stock.
The record shows a net $43.8K bought by insiders over 180 days, 19 funds added last quarter. Each figure is a federal filing, dated the day it went public.
PETS financials
Revenue growth
-21.1%
XBRL, annual
Net margin
-32.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$168.9M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM PETS
| FY Mar 2026 | $179.0M |
| FY Mar 2025 | $227.0M |
| FY Mar 2024 | $281.1M |
| FY Mar 2023 | $256.9M |
| FY Mar 2022 | $273.4M |
| Jun 2026 | $41.0M |
| Mar 2026 | $42.8M |
| Dec 2025 | $40.7M |
| Sep 2025 | $44.4M |
| Jun 2025 | $51.2M |
| Mar 2025 | $46.5M |
| Dec 2024 | $53.0M |
| Sep 2024 | $59.6M |
At each fiscal year end
Single quarter
Net margin, TTM
-17.3%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM PETS
| FY Mar 2026 | -32.0% |
| FY Mar 2025 | -2.8% |
| FY Mar 2024 | -2.7% |
| FY Mar 2023 | +2.0% |
| FY Mar 2022 | +6.8% |
| Jun 2026 | -15.0% |
| Mar 2026 | -9.5% |
| Dec 2025 | -26.0% |
| Sep 2025 | -19.2% |
| Jun 2025 | -66.7% |
| Mar 2025 | -25.1% |
| Dec 2024 | -1.3% |
| Sep 2024 | +3.9% |
At each fiscal year end
Single quarter
Free cash flow, TTM
-$27.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM PETS
| FY Mar 2026 | -$33.0M |
| FY Mar 2025 | -$395.0K |
| FY Mar 2024 | -$194.0K |
| FY Mar 2023 | $22.5M |
| FY Mar 2022 | $16.7M |
| Jun 2026 | -$8.3M |
| Mar 2026 | -$5.5M |
| Dec 2025 | -$9.2M |
| Sep 2025 | -$4.8M |
| Jun 2025 | -$13.6M |
| Mar 2025 | $4.6M |
| Dec 2024 | -$1.9M |
| Sep 2024 | $6.1M |
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity PETS
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt PETS
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-78.6%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity PETS
| FY Mar 2026 | -100.4% |
| FY Mar 2025 | -6.9% |
| FY Mar 2024 | -7.2% |
| FY Mar 2023 | +4.4% |
| FY Mar 2022 | +15.1% |
| Jun 2026 | -78.6% |
| Mar 2026 | -100.4% |
| Dec 2025 | -100.6% |
| Sep 2025 | -78.9% |
| Jun 2025 | -60.9% |
| Mar 2025 | -6.9% |
| Dec 2024 | +0.4% |
| Sep 2024 | -1.0% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-33.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets PETS
| FY Mar 2026 | -49.8% |
| FY Mar 2025 | -3.9% |
| FY Mar 2024 | -4.4% |
| FY Mar 2023 | +3.0% |
| FY Mar 2022 | +10.2% |
| Jun 2026 | -33.7% |
| Mar 2026 | -49.8% |
| Dec 2025 | -55.7% |
| Sep 2025 | -44.7% |
| Jun 2025 | -33.7% |
| Mar 2025 | -3.9% |
| Dec 2024 | +0.2% |
| Sep 2024 | -0.6% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital PETS
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-81.6%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed PETS
| FY Mar 2026 | -102.0% |
| FY Mar 2025 | -1.7% |
| FY Mar 2024 | -7.9% |
| FY Mar 2023 | +5.2% |
| FY Mar 2022 | n/a |
| Jun 2026 | -81.6% |
| Mar 2026 | -102.0% |
| Dec 2025 | -90.7% |
| Sep 2025 | -69.6% |
| Jun 2025 | -54.6% |
| Mar 2025 | -1.7% |
| Dec 2024 | +0.7% |
| Sep 2024 | -2.0% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing PETS
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | 64.96x |
| FY Mar 2022 | 24.81x |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | 482.00x |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value PETS
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-105.0%
TTM free cash flow over market value at close 2026-10-23
FCF yield PETS
| FY Mar 2026 | -67.7% |
| FY Mar 2025 | -0.5% |
| FY Mar 2024 | -0.2% |
| FY Mar 2023 | +6.6% |
| FY Mar 2022 | +3.1% |
| Jun 2026 | -67.7% |
| Mar 2026 | -67.7% |
| Dec 2025 | -33.5% |
| Sep 2025 | -29.7% |
| Jun 2025 | -6.9% |
| Mar 2025 | -0.5% |
| Dec 2024 | +0.9% |
| Sep 2024 | -1.2% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing PETS
| FY Mar 2026 | n/a |
| FY Mar 2025 | n/a |
| FY Mar 2024 | n/a |
| FY Mar 2023 | n/a |
| FY Mar 2022 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2026-03 | 2025-03 | 2024-03 | 2023-03 | |
|---|---|---|---|---|
| Revenue | $179.0M | $227.0M | $281.1M | $256.9M |
| Gross profit | $50.2M | $69.1M | $84.8M | $76.5M |
| Operating income | -$58.7M | -$1.5M | -$8.2M | $6.1M |
| Net income | -$57.3M | -$6.3M | -$7.5M | $5.1M |
| EPS (diluted) | -2.74 | -0.30 | -0.37 | 0.25 |
| Operating cash flow | -$28.4M | $4.7M | $4.3M | $27.8M |
| Cash | $21.4M | $54.7M | $55.3M | $104.1M |
| Dividends paid | $21.0K | $181.0K | $12.4M | $24.5M |
SEC XBRL, fiscal years, as known on 2026-10-27
PETS Stock Sonar score 5/7 axes
Find similar shapesComparePETS ranks highest on risk and compliance (72nd percentile) and insider conviction (67th), and lowest on profitability (9th), among Wholesale & Retail peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
PETS filings, in plain words
Are Petmed Express insiders buying or selling PETS?
In the 180 days to 2026-10-27, Petmed Express insiders were net buyers, a net $43.8K across purchases and sales reported on Form 4, by 1 buyer.
Read the full summary
In the 180 days to 2026-10-27, Petmed Express insiders were net buyers of PETS, a net $43.8K across purchases and sales reported on Form 4 by 1 buyer. Most of that figure, $43.8K, came from a holder of 10% or more rather than an officer or director. The latest 5% ownership filing is a 13D by Diveroli Investment Group LLC, filed 2026-02-11, for 1.8% of the class. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
